LINK: https://bswhealth.webex.com/bswhealth/j.php?MTID=m8656cefb59392dddc2b165b50ccd7471

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Review the Scientific Rationale for Cell-Based Diabetes Therapies. (2) Analyze Key Advances and Challenges in Beta-Cell Differentiation. (3) Evaluate the Clinical Translation and Future of Stem Cell Therapies for Diabetes.

FACULTY DISCLOSURE: Sebastian Danobeitia, MD, has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: Robert Goldstein, MD, Sumeet Asrani, MD, and Kathy Brown, RN, CCTC, have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC: Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

CEPTC Credit: The American Board for Transplant Certification (ABTC) has been applied for educational offering for up to 1 Category 1 Continuing Education Point for Transplant Certification (CEPTCs).

For information, please contact Karina Pena at karina.pena@bswhealth.org